ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
Babbanap
|
52 |
18K |
6 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
52
|
18K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
Babbanap
|
52 |
18K |
3 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
52
|
18K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Babbanap
|
4.4K |
2.0M |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
Babbanap
|
117 |
54K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
117
|
54K
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
Babbanap
|
117 |
54K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
117
|
54K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Babbanap
|
4.2K |
3.8M |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
Babbanap
|
117 |
54K |
6 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
117
|
54K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Babbanap
|
92 |
42K |
2 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
92
|
42K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Shareholders got stooged from AFL hype
|
|
Babbanap
|
11 |
5.1K |
0 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
11
|
5.1K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Shareholders got stooged from AFL hype
|
|
Babbanap
|
11 |
5.1K |
5 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
11
|
5.1K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Babbanap
|
92 |
42K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
92
|
42K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Babbanap
|
92 |
42K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
92
|
42K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Babbanap
|
92 |
42K |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
92
|
42K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Babbanap
|
92 |
42K |
10 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
92
|
42K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Babbanap
|
92 |
42K |
10 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
92
|
42K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
4 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
706
|
255K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
706
|
255K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
8 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
706
|
255K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
261K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
261K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
261K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
261K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
2x2 Yay Or Nay From The FDA?
|
|
Babbanap
|
13 |
4.9K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
13
|
4.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
706
|
255K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
18K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
18K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
706
|
255K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
12 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
706
|
255K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
18K |
11 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
18K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
18K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
18K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
18K |
16 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
18K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
18K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
18K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
706
|
255K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
18K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
18K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
11 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
706
|
255K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
706
|
255K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
8 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
706
|
255K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
706
|
255K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
706
|
255K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
7 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
706
|
255K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
706
|
255K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
706
|
255K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
706
|
255K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
28 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
706
|
255K
|
28
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
21 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
706
|
255K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
706
|
255K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
10 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
706
|
255K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
261K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
670
|
261K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
261K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
670
|
261K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
706
|
255K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
261K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
670
|
261K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
706
|
255K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
706 |
255K |
5 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
706
|
255K
|
5
|
|